n.dziedzic
TL2 Moderator · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 28 May 2025 · last posted 6d
84 posts, newest first. Showing up to 150.
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #19 · Compounds › Semaglutide · 22 Jul 2026 · 8 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #120 · Evidence › Journal club · 20 Jul 2026 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Comparing documentation quality across the directory, tabulated Replied, post #10 · Sourcing › Vendor reports · 14 Jul 2026 · 18 likes Picking up post #7: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Micro-titration: a disputed topic, argued properly Replied, post #104 · Practice › Dosing & titration · 13 Jul 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #27 · Clinical › Comorbidities · 11 Jul 2026 · 22 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Journal club: LEADER as the historical anchor Replied, post #102 · Evidence › Journal club · 10 Jul 2026 · 1 like On post #98 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
How shortages have affected compounding permissions Replied, post #24 · Access › Shortages · 8 Jul 2026 · 24 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Programming during a large energy deficit Replied, post #32 · Nutrition & Training › Resistance training · 5 Jul 2026 · 1 like Worth separating two things that post #28 runs together. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #50 · Access › International · 2 Jul 2026 · 1 like Picking up post #47: that is the part I would want checked first. Insurance and coverage: coverage decisions are national. A compound approved in one country might not…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #51 · Clinical › Bloodwork · 2 Jul 2026 · 19 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Revisiting: The best-written scientific paper you have read Replied, post #61 · Lounge › Off topic · 30 Jun 2026 · 16 likes This follows post #58 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #48 · Start Here › Welcome · 28 Jun 2026 · 17 likes I read post #46 twice before replying, because I had assumed the opposite. Welcome. The orientation materials are pinned at the top of this category and they take about…
-
Injecting into an area that has become firm: why not to Replied, post #55 · Practice › Administration · 12 Jun 2026 · 1 like Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #41 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 28 likes Worth separating two things that post #37 runs together. Method validation is the demonstration that a method can separate the compound from its degradation products…
-
Why this subcategory is stricter about sourcing than most Replied, post #36 · Compounds › Secretagogues & GH axis · 30 May 2026 · 29 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #17 · Start Here › Welcome · 29 May 2026 · 1 like Coming back to post #15, because the follow-up matters more than the original answer. The moderation log is public. Every staff action is logged with the rule cited and…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #19 · Compounds › Oral incretins · 2 May 2026 · 0 likes On post #15 — agreed on the reasoning, with one qualification. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority…
-
Does a peptide degrade silently, with no visual change? Replied, post #16 · Practice › Storage & stability · 26 Apr 2026 · 8 likes Worth separating two things that post #12 runs together. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #47 · Sourcing › Logistics · 20 Apr 2026 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #20 · Evidence › Journal club · 2 Apr 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #21 · Practice › Storage & stability · 24 Mar 2026 · 25 likes Coming back to post #19, because the follow-up matters more than the original answer. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals…
-
Grapefruit: why this class is not the class that cares Replied, post #67 · Practice › Interactions · 22 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Search filters: what is missing Replied, post #38 · Meta › Site feedback · 21 Mar 2026 · 0 likes Coming back to post #36, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: Maintainer handover: how it works Replied, post #35 · Meta › Wiki maintenance · 7 Mar 2026 · 26 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Bioimpedance and hydration: why the number moves Replied, post #14 · Outcomes › Body composition · 5 Mar 2026 · 21 likes Worth separating two things that post #10 runs together. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent.…
-
Grapefruit: why this class is not the class that cares Replied, post #5 · Practice › Interactions · 2 Mar 2026 · 32 likes Worth separating two things that the opening post runs together. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not…
-
The headache that turns out to be dehydration — the long version Started this topic · Nutrition & Training › Hydration & electrolytes · 12 Feb 2026 · 0 likes On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. Longitudinal report with the…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #54 · Start Here › How to Ask · 19 Jan 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
What to include when your question involves a chromatogram Replied, post #55 · Start Here › How to Ask · 19 Jan 2026 · 23 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #22 · Data & Tools › Calculators · 14 Jan 2026 · 4 likes Worth separating two things that post #18 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
A partial dose because the pen emptied mid-injection Replied, post #104 · Practice › Administration · 10 Jan 2026 · 1 like Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Reading an interaction checker output critically Replied, post #87 · Practice › Interactions · 8 Jan 2026 · 0 likes post #86 answers the question as asked. The question underneath it is different. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #30 · Practice › Interactions · 8 Jan 2026 · 1 like On post #26 — agreed on the reasoning, with one qualification. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #9 · Clinical › Special populations · 7 Jan 2026 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #93 · Analytics › COA interpretation · 19 Dec 2025 · 12 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Prescription requirements and telehealth models Replied, post #64 · Sourcing › Regulatory · 13 Dec 2025 · 5 likes This follows post #61 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #112 · Practice › Reconstitution · 3 Dec 2025 · 5 likes On post #108 — agreed on the reasoning, with one qualification. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #78 · Analytics › COA interpretation · 26 Nov 2025 · 6 likes Worth separating two things that post #74 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Started this topic · Practice › Side effects · 20 Nov 2025 · 0 likes On the subject in the title: Injection-site reactions: describing them precisely enough to be useful Working notes rather than a conclusion. Reporting something rather…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #62 · Compounds › Oral incretins · 16 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #116 · Practice › Storage & stability · 2 Nov 2025 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Reconciling a supplier certificate with an independent result Replied, post #18 · Sourcing › Vendor reports · 30 Oct 2025 · 7 likes On post #14 — agreed on the reasoning, with one qualification. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #25 · Documentation › Doc review · 28 Oct 2025 · 1 like I read post #23 twice before replying, because I had assumed the opposite. Review date disputes: if a maintained page's review date is approaching and it has not been…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #110 · Practice › Storage & stability · 25 Oct 2025 · 28 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #38 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Comparing my trajectory with the trial curves, carefully Replied, post #57 · Outcomes › Progress reports · 4 Oct 2025 · 15 likes On post #53 — agreed on the reasoning, with one qualification. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #124 · Evidence › Study critique · 16 Sep 2025 · 10 likes On post #120 — agreed on the reasoning, with one qualification. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #57 · Practice › Reconstitution · 10 Sep 2025 · 7 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #73 · Devices › Cold chain · 7 Sep 2025 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Why appetite effects are mostly central Replied, post #30 · Pharmacology › Receptor biology · 1 Sep 2025 · 0 likes On post #26 — agreed on the reasoning, with one qualification. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #28 · Compounds › Tirzepatide · 28 Aug 2025 · 5 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Asking about a compound your prescriber has not heard of Replied, post #133 · Clinical › Prescriber conversations · 21 Aug 2025 · 1 like Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Hypertension improvement and when medication needs revisiting Replied, post #9 · Clinical › Comorbidities · 14 Aug 2025 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #17 · Compounds › Secretagogues & GH axis · 31 Jul 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Immortal time bias in a claims-database study Replied, post #7 · Evidence › Study critique · 26 Jul 2025 · 2 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
A preprint whose numbers changed substantially at publication Replied, post #3 · Evidence › Preprints · 26 Jul 2025 · 14 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Why the timeline is on the right and not the left Replied, post #44 · Meta › Site feedback · 22 Jul 2025 · 33 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
A field-by-field walk through a certificate of analysis Replied, post #138 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #111 · Wellbeing › Mental health · 2 Jul 2025 · 23 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #30 · Access › Insurance & coverage · 30 Jun 2025 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #14 · Sourcing › Red flags · 22 Jun 2025 · 0 likes post #13 answers the question as asked. The question underneath it is different. Pricing patterns: unusually low prices for what are otherwise consistent with market…
-
Half-life, steady state, and accumulation worked through Replied, post #88 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Half-life, steady state, and accumulation worked through Replied, post #63 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 0 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
A claim built entirely on a subgroup analysis Replied, post #70 · Evidence › Study critique · 2 Jun 2025 · 7 likes post #69 answers the question as asked. The question underneath it is different. Choosing the worst interpretation: "The confidence interval includes a harmful effect"…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #3 · Evidence › Trials · 28 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why plausible mechanism is not evidence of effect Replied, post #12 · Compounds › Repair & healing peptides · 27 May 2025 · 2 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Antibiotics and a course of something with delayed emptying Replied, post #42 · Practice › Interactions · 16 May 2025 · 1 like Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #32 · Clinical › Comorbidities · 12 May 2025 · 18 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Follow-up: What other technical communities get right that we do not Replied, post #85 · Lounge › Off topic · 2 May 2025 · 22 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Requesting a page: what makes a good request Replied, post #28 · Documentation › Wiki requests · 19 Mar 2025 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Started this topic · Evidence › Journal club · 9 Mar 2025 · 0 likes On the subject in the title: Journal club: the retatrutide phase 2 obesity paper Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022)…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #12 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Protein density versus volume when you cannot eat much Replied, post #4 · Nutrition & Training › Protein & intake · 22 Jan 2025 · 7 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #125 · Compounds › Oral incretins · 28 Dec 2024 · 29 likes post #124 is right about the mechanism and I think understates the practical bit. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple…
-
Why "any advice?" is the least effective ending for a post Replied, post #84 · Start Here › How to Ask · 28 Nov 2024 · 5 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
What changed in 2026, by region Replied, post #2 · Access › International · 28 Nov 2024 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #19 · Practice › Reconstitution · 19 Nov 2024 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #65 · Analytics › Method validation · 3 Nov 2024 · 2 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #97 · Analytics › COA interpretation · 27 Oct 2024 · 4 likes Picking up post #94: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #43 · Compounds › Retatrutide · 17 Sep 2024 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Blind submission and why it changes minds Replied, post #55 · Sourcing › Independent verification · 7 Sep 2024 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
About the Off topic category Replied, post #3 · Lounge › Off topic · 26 Aug 2024 · 30 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
How this community labels and discusses unrefereed work Replied, post #79 · Evidence › Preprints · 12 Jul 2024 · 16 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Why I ask for the gradient before I discuss the number Replied, post #4 · Analytics › HPLC & UHPLC · 28 Jun 2024 · 23 likes post #3 answers the question as asked. The question underneath it is different. Gradient slope is the single biggest driver of apparent purity differences. A shallower…